Trial Profile
Tamsulosin for the treatment of lower urinary tract symptoms associated with ureteric stenting
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Aug 2013
Price :
$35
*
At a glance
- Drugs Tamsulosin (Primary)
- Indications Lower urinary tract symptoms
- Focus Therapeutic Use
- 30 Aug 2013 Results presented at the 43rd Annual Meeting of the International Continence Society.
- 02 Aug 2013 New trial record